Navigation Links
Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA
Date:4/28/2009

DALLAS, April 28 /PRNewswire/ -- BeaconEquity.com announces the availability of Stock Alerts on stocks making news today. As the influenza dominates the headlines, several biopharmaceutical stocks are parading up the charts.

So how does swine flu affect the markets? Check out a video chart for three stocks (BCRX, AVII, DVAX) reeling from influenza news that should be on your radar this week at stockhideout.com.

Today's Stock Alerts include: Hemispherx Biopharma Inc. (AMEX: HEB), Generex Biotechnology Corp. (Nasdaq: GNBT), BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX), Dynavax Technologies Corp. (Nasdaq: DVAX), Novavax Inc. (Nasdaq: NVAX) and Sinovac Biotech Ltd. (AMEX: SVA).

Investors can view all of the daily stock alerts for free by visiting BeaconEquity.com/m.

See what Cramer has to say about these stocks and many more.

BeaconEquity.com's Stock Alerts are brief analyses on the active stocks each day th
'/>"/>

SOURCE BeaconEquity.com
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
2. Companys Partner Completes Trial Production of a New Antiviral Medicine
3. Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray
4. INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
7. Neuralstem Shares Accepted for Trading on Amex(R)
8. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
9. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
10. Essilor Cancels 700,000 Shares
11. Helix BioPharma announces $16.9 million private placement of common shares
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3